Search Results
Jul 07, 2026, 06:33 ET ADMA Investment Deadline: ADMA Biologics Securities Fraud Class Action Focuses on Channel Stuffing Allegations; Investors Notified of August 10 Court Deadline
investors in ADMA securities. The class action is pending in the U.S. District Court for the District of New Jersey. It is captioned Mazzarino v. ADMA Biologics, Inc., et al., No. 26-cv-6918.Why is ADMA Biologics Being Sued for Securities Fraud? ADMA has been sued
More news about: Bleichmar Fonti & Auld LLP
Jul 06, 2026, 17:00 ET ADMA Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages ADMA Investors with Losses to Contact the Firm
Did you buy ADMA securities between August 9, 2024 and March 25, 2026?Affected ADMA Investor SummaryWho: ADMA Biologics, Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Jul 06, 2026, 13:57 ET ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations
More news about: DJS Law Group LLP
Jul 06, 2026, 13:57 ET ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of
More news about: The Schall Law Firm
Jul 03, 2026, 22:00 ET ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
ADMA Biologics, Inc. ("ADMA" or the "Company") (NasdaqGM: ADMA) of a class action securities lawsuit.
More news about: Kahn Swick & Foti, LLC
Jul 02, 2026, 09:23 ET ADMA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
failing to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; and (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: Faruqi & Faruqi, LLP
Jul 02, 2026, 01:12 ET ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; and (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: THE ROSEN LAW FIRM, P. A.
Jul 01, 2026, 15:26 ET ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
lawsuit against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA).
More news about: Glancy Prongay Wolke & Rotter LLP
Jul 01, 2026, 10:07 ET ADMA DEADLINE: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline
hundreds of millions of dollars for investors.Frequently Asked Questions About the ADMA LawsuitQ: Who is eligible to join the ADMA investor lawsuit? A: Investors who purchased ADMA stock or securities between August 9, 2024 and March 25, 2026 and suffered financial losses may
More news about: Levi & Korsinsky, LLP
Jun 30, 2026, 21:07 ET ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
Did you buy ADMA securities between August 9, 2024 and March 25, 2026?Affected ADMA Investor SummaryWho: ADMA Biologics, Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Jun 30, 2026, 06:14 ET $ADMA Notification: ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securities Fraud Class Action
investors in ADMA securities. The class action is pending in the U.S. District Court for the District of New Jersey. It is captioned Mazzarino v. ADMA Biologics, Inc., et al., No. 26-cv-6918.Why is ADMA Biologics Being Sued for Securities Fraud? ADMA has been sued
More news about: Bleichmar Fonti & Auld LLP
Jun 29, 2026, 07:00 ET ADMA INVESTOR NOTICE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
of ADMA Biologics, Inc. (NASDAQ: ADMA) publicly traded securities between August 9, 2024 and March 25, 2026, inclusive (the "Class Period"), have until Monday, August 10, 2026 to seek appointment as lead plaintiff of the ADMA Biologics class action lawsuit. Captioned Mazzarino v. ADMA Biologics,
More news about: Robbins Geller Rudman & Dowd LLP
Jun 26, 2026, 22:00 ET ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
ADMA Biologics, Inc. (NasdaqGM: ADMA) ("ADMA" or the "Company"), if they purchased or otherwise acquired the Company's securities between August 9, 2024 and March 25, 2026,
More news about: ClaimsFiler
Jun 26, 2026, 18:00 ET ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; and (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: THE ROSEN LAW FIRM, P. A.
Jun 25, 2026, 12:00 ET ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
investors with losses related to ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA) have opportunity to lead
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Jun 25, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines - ADMA
June 25, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jun 25, 2026, 05:24 ET ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of
More news about: The Schall Law Firm
Jun 25, 2026, 04:01 ET ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA) for violations of
More news about: DJS Law Group LLP
Jun 24, 2026, 18:03 ET ADMA Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages ADMA Investors with Losses to Contact the Firm
Did you buy ADMA securities between August 9, 2024 and March 25, 2026?Affected ADMA Investor SummaryWho: ADMA Biologics, Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Jun 24, 2026, 10:07 ET ADMA Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in ADMA BIOLOGICS, INC. Securities Lawsuit - Contact Levi & Korsinsky
growth into an estimated 3% decline. Between these dates, investors purchased ADMA (NASDAQ: ADMA) shares without knowledge of what was allegedly occurring behind the scenes.WHO IS AFFECTED: Those who purchased ADMA securities between August 9, 2024 and March 25, 2026 may be entitled to
More news about: Levi & Korsinsky, LLP
Jun 23, 2026, 19:33 ET Robbins LLP Urges ADMA Stockholders Who Lost Money Investing in ADMA Biologics, Inc. Contact the Firm for Information About Leading the Class Action
stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ: ADMA) securities between August 9,2024 and March 25, 2026. ADMA Biologics, Inc., is a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived
More news about: Robbins LLP
Jun 23, 2026, 15:22 ET ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
lawsuit against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). IF
More news about: Law Offices of Howard G. Smith
Jun 23, 2026, 10:02 ET ADMA Shareholder Alert: ADMA Biologics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; (4) as a result, defendants' statements about ADMA Biologics' business, operations,
More news about: The Gross Law Firm
Jun 23, 2026, 06:43 ET ADMA Class Notice: ADMA Biologics Investors that Suffered Losses are Notified of the Imminent August 10 Securities Class Action Deadline
investors in ADMA securities. The class action is pending in the U.S. District Court for the District of New Jersey. It is captioned Mazzarino v. ADMA Biologics, Inc., et al., No. 26-cv-6918.Why is ADMA Biologics Being Sued for Securities Fraud? ADMA has been sued
More news about: Bleichmar Fonti & Auld LLP
Jun 23, 2026, 05:40 ET INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
acquirers of ADMA Biologics, Inc. (NASDAQ: ADMA) publicly traded securities between August 9, 2024 and March 25, 2026, inclusive (the "Class Period"), have until August 10, 2026 to seek appointment as lead plaintiff of the ADMA Biologics class action lawsuit. Captioned Mazzarino v. ADMA Biologics,
More news about: Robbins Geller Rudman & Dowd LLP